Abstract:Nucleoside/tide analogs are now widely used for treatment of chronic hepatitis B (CHB). However, available nucleoside/tide analogs for treatment of CHB usually have limited therapeutic effect and potential adverse effects on CHB patients. We evaluated the anti-HBV effects of three novel derivatives (compounds 1, 4, and 8) of adefovir on the replication of hepatitis B virus (HBV) and determined their cytotoxicity. The effects of those compounds on the replication of human HBV in the HepG2 2.2.15 cell line and duck HBV in infected ducks were characterized by measuring the extracellular and intracellular HBV DNA using the quantitative real-time PCR and Southern blot assays. Their cytotoxicities against HepG2 cells were evaluated by MTT and measuring the contents of mitochondrial DNA using the dot blot assay. We found that all of the compounds inhibited the production of HBV in a dose-dependent manner, similar to that of adefovir dipivoxil. Furthermore, treatment with any of the compounds reduced significantly the replication of DHBV in ducks, accompanied by a significant reduction of inflammation in the livers, and the compound 1 appeared to be a fast-acting and long-lasting anti-DHBV reagent. Importantly, all of the compounds showed little cytotoxicity against HepG2 cells, even at a concentration of 1 mM. Collectively, those novel derivatives of adefovir had potent anti-HBV activity with little adverse effect and may be therapeutic candidates for potential clinical studies.

Synthesis and Antiviral Activity of New Acrylamide Derivatives Containing 1,2,3-Thiadiazole As Inhibitors of Hepatitis B Virus Replication

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

Design and Synthesis of (3-Phenylisoxazol-5-yl)methanimine Derivatives as Hepatitis B Virus Inhibitors

1H-1,2,3-Triazol-1-yl acetate derivatives and in vitro anti-HBV activity

Discovery and Biological Evaluation of 2-((3-phenylisoxazol-5-yl) Methoxy) Benzamide Derivatives As Potent Nucleocapsid Inhibitors

Synthesis and Evaluation of 3-Phenylisoxazoline Derivatives As Non-Nucleoside Hepatitis B Virus Inhibitors

Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives

Synthesis and Biological Evaluation of Triazolo-pyrimidine Derivatives As Novel Inhibitors of Hepatitis B Virus Surface Antigen (hbsag) Secretion

Synthesis and Anti‐HBV Activities Evaluation of New Ethyl 8‐imidazolylmethyl‐7‐hydroxyquinoline‐3‐carboxylate Derivatives in Vitro

5-Iodo-2-arylalkylthio-6-aryl pyrimidin-4(3H)-ones as non-nucleoside anti-HBV agents

Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.

Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives.

Design, Synthesis, Molecular Docking Studies and Anti-Hbv Activity of Phenylpropanoid Derivatives

Synthesis and Antiviral Activity of (E)-3-(4- or 6-Methylbenzo[d]thiazol-2-yl-amino)-2-cyano-3-(methylthio)acrylate Derivatives

Design, synthesis, and biological evaluation of novel (E)-1-arylethan-1-one O-((3-arylisoxazol-5-yl) methyl) oxime derivatives as potent non-nucleoside HBV inhibitors

Synthesis and Anti-HBV Activity of Novel Dihydropyrimidine Analogs

Antiviral Effects of Three Novel Derivatives of Adefovir on the Replication of Hepatitis B Virus

Synthesis of telbivudine 3'-O-acetyl-5'-O-phenyl-N-alkylphosphramidates and evaluation of their anti-HBV activities

Synthesis and Biological Evaluation of Phenylpropanoid Derivatives

Design and Synthesis of Novel Benzimidazole Derivatives As Inhibitors of Hepatitis B Virus

Design, Synthesis, and Evaluation of Novel Heteroaryldihydropyrimidine Derivatives As Non‐nucleoside Hepatitis B Virus Inhibitors by Exploring the Solvent‐exposed Region